Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 USD | +10.61% | -2.99% | +117.91% |
May. 07 | Transcript : Trevi Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Trevi Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 186M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -52M | EV / Sales 2024 * | - |
Net cash position 2024 * | 107M | Net cash position 2025 * | 188M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.87
x | P/E ratio 2025 * |
-6.03
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.65% |
Latest transcript on Trevi Therapeutics, Inc.
1 day | +10.61% | ||
1 week | -2.99% | ||
Current month | -0.34% | ||
1 month | +1.39% | ||
3 months | +78.05% | ||
6 months | +115.50% | ||
Current year | +117.91% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Thomas Sciascia
FOU | Founder | 70 | 10-12-31 |
Lisa Delfini
DFI | Director of Finance/CFO | 54 | 21-08-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne VanLent
BRD | Director/Board Member | 76 | 18-10-09 |
James Cassella
BRD | Director/Board Member | 69 | 20-02-12 |
Jennifer Good
FOU | Founder | 59 | 11-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +3.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 2.64 | -8.97% | 116,736 |
24-05-07 | 2.9 | -1.36% | 81,887 |
24-05-06 | 2.94 | -2.65% | 46,713 |
24-05-03 | 3.02 | +0.33% | 26,782 |
24-05-02 | 3.01 | +5.24% | 91,385 |
Delayed Quote Nasdaq, May 09, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+117.91% | 186M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- TRVI Stock